The urge to lose weight quickly is common, but as any self-respecting nutritionist will tell you, crash diets, pills and anything else promising a quick fix should, at best, be approached with extreme ...

A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial, as the drugmaker tries to fend off a marketplace challenge from Eli Lilly. A 7.2mg ...